Case number 2016-2348
Cephalon Inc. v. Hetero Labs Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 16, 2017 | 34 | ORDER reactivating case; granting motion to terminate appeal [33] filed by Appellants Hospira, Inc., InnoPharma Inc. and Appellee Cephalon Inc.; issuing mandate. Service as of this date by Clerk of Court. [454480] [MJL] [Entered: 08/16/2017 03:20 PM] (2) |
| Aug 16, 2017 | 33 | MOTION of Appellants Hospira, Inc., InnoPharma Inc. and Appellee Cephalon Inc. to terminate appeal through DISMISSAL PURSUANT TO FED. R. APP. P. 42(B). [Consent: unopposed]. Service: 08/16/2017 by email. [454425] [Sara Horton] [Entered: 08/16/2017 02:04 PM] (6) |
| Aug 11, 2017 | 32 | ORDER filed. If the appellants wish to dismiss this appeal, they are directed to file their motion to dismiss within 7 days of the date of filing of this order. Service: 08/11/2017 by clerk. [453465] [NL] [Entered: 08/11/2017 03:33 PM] (2) |
| Jul 31, 2017 | 31 | Notice from Appellee Cephalon Inc. Joint Notice of District Court's Entry of Final Judgment. Service: 07/31/2017 by email. [450329] [William Jay] [Entered: 07/31/2017 11:05 AM] (5) |
| Aug 15, 2016 | 30 | ORDER filed. The motion [29] is granted. The parties shall inform this court within 40 days from the date of entry of final judgment how they believe this appeal should proceed. Service: 08/15/2016 by clerk. [358852] [LMS] [Entered: 08/15/2016 03:06 PM] (2) |
| Aug 11, 2016 | 29 | MOTION of Appellee Cephalon Inc. to deactivate appeal. Response/Opposition is due 08/25/2016 [Consent: unopposed]. Service: 08/11/2016 by email, US mail. [358207] [William Jay] [Entered: 08/11/2016 05:13 PM] (8) |
| Aug 3, 2016 | 28 | Corrected Docketing Statement for the Appellants Hospira, Inc. and InnoPharma Inc.. Service: 08/03/2016 by email. [355763] [Sara Horton] [Entered: 08/03/2016 12:27 PM] (4) |
| Aug 3, 2016 | 27 | Corrected Docketing Statement for the Appellant Sagent Pharmaceuticals, Inc.. Service: 08/03/2016 by email, US mail. [355753] [Ronald Daignault] [Entered: 08/03/2016 11:58 AM] (4) |
| Aug 3, 2016 | 26 | Corrected Docketing Statement for the Appellants Accord Healthcare Inc. and Intas Pharmaceuticals Limited. Service: 08/03/2016 by email. [355743] [Mark Boland] [Entered: 08/03/2016 11:39 AM] (4) |
| Aug 3, 2016 | 25 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Azadeh S. Kokabi and Michael R. Dzwonczyk (entries of appearance [6] and [9]) are not registered CM/ECF filers for the Federal Circuit. CORRECTION: Pursuant to FCR 25(a)(2), attorneys who appear before this court must register for the court's CM/ECF system. Please register promptly. [355635] [MJL] [Entered: 08/03/2016 08:23 AM] (0) |
| Aug 3, 2016 | 24 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: The contact information included on the entry of appearance for Ronald M. Daignault [10] does not match the contact information in the attorney's user account. CORRECTION: Please update as needed to ensure the contact information on the entry of appearance and in the user account matches. [355632] [MJL] [Entered: 08/03/2016 08:17 AM] (0) |
| Aug 3, 2016 | 23 | NOTICE OF DEFICIENCY: The docketing statements filed by Appellants Hospira Inc. and InnoPharma Inc. [3], Accord Healthcare Inc. and Intas Pharmaceuticals [7], and Sagent Pharmaceuticals, Inc. [11] in 16-2348 are incomplete and therefore cannot be accepted for filing at this time. The statement on related cases was left blank. You are being afforded the opportunity to correct the deficiency. Please ensure all questions are filled out. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [355630] [MJL] [Entered: 08/03/2016 08:14 AM] (0) |
| Aug 2, 2016 | 22 | Entry of appearance for Yusuf Esat as of counsel for Appellants Hospira, Inc. and InnoPharma Inc.. Service: 08/02/2016 by email. [355524] [Yusuf Esat] [Entered: 08/02/2016 03:16 PM] (2) |
| Aug 1, 2016 | 14 | Certificate of Interest for the Appellee Cephalon Inc.. Service: 08/01/2016 by email, US mail. [355179] [William Jay] [Entered: 08/01/2016 06:36 PM] (2) |
| Aug 1, 2016 | 15 | Entry of appearance for William M. Jay as principal counsel for Appellee Cephalon Inc.. Service: 08/01/2016 by email, US mail. [355180] [William Jay] [Entered: 08/01/2016 06:39 PM] (2) |
| Aug 1, 2016 | 16 | Entry of appearance for Daryl L. Wiesen as of counsel for Appellee Cephalon Inc.. Service: 08/01/2016 by email, US mail. [355182] [Daryl Wiesen] [Entered: 08/01/2016 06:44 PM] (2) |
| Aug 1, 2016 | 17 | Entry of appearance for David M. Hashmall as of counsel for Appellee Cephalon Inc.. Service: 08/01/2016 by email, US mail. [355184] [David Hashmall] [Entered: 08/01/2016 06:48 PM] (2) |
| Aug 1, 2016 | 18 | Entry of appearance for Emily L. Rapalino as of counsel for Appellee Cephalon Inc.. Service: 08/01/2016 by email, US mail. [355186] [Emily Rapalino] [Entered: 08/01/2016 06:52 PM] (2) |
| Aug 1, 2016 | 19 | Entry of appearance for Nicholas K. Mitrokostas as of counsel for Appellee Cephalon Inc.. Service: 08/01/2016 by email, US mail. [355187] [Nicholas Mitrokostas] [Entered: 08/01/2016 06:56 PM] (2) |
| Aug 1, 2016 | 20 | Entry of appearance for Calvin E. Wingfield Jr. as of counsel for Appellee Cephalon Inc.. Service: 08/01/2016 by email, US mail. [355189] [Calvin Wingfield] [Entered: 08/01/2016 06:59 PM] (2) |
| Aug 1, 2016 | 21 | Letter from Appellee Cephalon Inc. Regarding Appellants Premature Notice of Appeal. Service: 08/01/2016 by email, US mail. [355193] [William Jay] [Entered: 08/01/2016 07:12 PM] (2) |
| Aug 1, 2016 | 13 | Docketing Statement for the Appellee Cephalon Inc.. Service: 08/01/2016 by email, US mail. [355177] [William Jay] [Entered: 08/01/2016 06:34 PM] (4) |
| Aug 1, 2016 | 12 | Certificate of Interest for the Appellant Sagent Pharmaceuticals, Inc.. Service: 08/01/2016 by email, US mail. [355164] [Ronald Daignault] [Entered: 08/01/2016 05:50 PM] (2) |
| Aug 1, 2016 | 11 | Docketing Statement for the Appellant Sagent Pharmaceuticals, Inc.. Service: 08/01/2016 by email, US mail. [355163] [Ronald Daignault] [Entered: 08/01/2016 05:47 PM] (0) |
| Aug 1, 2016 | 10 | Entry of appearance for Ronald M. Daignault as principal counsel for Appellant Sagent Pharmaceuticals, Inc.. Service: 08/01/2016 by email. [355162] [Ronald Daignault] [Entered: 08/01/2016 05:42 PM] (2) |
| Aug 1, 2016 | 9 | Corrected Entry of appearance for Michael R. Dzwonczyk as principal counsel for Appellants Accord Healthcare Inc. and Intas Pharmaceuticals Limited. Service: 08/01/2016 by email. [355152] [Mark Boland] [Entered: 08/01/2016 05:04 PM] (2) |
| Aug 1, 2016 | 8 | Certificate of Interest for the Appellants Accord Healthcare Inc. and Intas Pharmaceuticals Limited. Service: 08/01/2016 by email. [355145] [Mark Boland] [Entered: 08/01/2016 04:59 PM] (2) |
| Aug 1, 2016 | 7 | Docketing Statement for the Appellants Accord Healthcare Inc. and Intas Pharmaceuticals Limited. Service: 08/01/2016 by email. [355142] [Mark Boland] [Entered: 08/01/2016 04:58 PM] (0) |
| Aug 1, 2016 | 6 | Entry of appearance for Azadeh S. Kokabi as of counsel for Appellants Accord Healthcare Inc. and Intas Pharmaceuticals Limited. Service: 08/01/2016 by email. [355139] [Mark Boland] [Entered: 08/01/2016 04:57 PM] (2) |
| Aug 1, 2016 | 5 | Entry of appearance for Michael R. Dzwonczyk as principal counsel for Appellant Accord Healthcare Inc.. Service: 08/01/2016 by email. [355137] [Mark Boland] [Entered: 08/01/2016 04:55 PM] (2) |
| Aug 1, 2016 | 4 | Certificate of Interest for the Appellants Hospira, Inc. and InnoPharma Inc.. Service: 08/01/2016 by email. [355118] [Sara Horton] [Entered: 08/01/2016 04:26 PM] (2) |
| Aug 1, 2016 | 3 | Docketing Statement for the Appellants Hospira, Inc. and InnoPharma Inc.. Service: 08/01/2016 by email. [355115] [Sara Horton] [Entered: 08/01/2016 04:24 PM] (0) |
| Aug 1, 2016 | 2 | Entry of appearance for Sara Tonnies Horton as principal counsel for Appellants Hospira, Inc. and InnoPharma Inc.. Service: 08/01/2016 by email. [355113] [Sara Horton] [Entered: 08/01/2016 04:21 PM] (2) |
| Jul 18, 2016 | 1 | Appeal docketed. Received: 07/12/2016. [351529]Entry of Appearance due 08/01/2016. Certificate of Interest is due on 08/01/2016. Docketing Statement due 08/01/2016. Appellant/Petitioner's brief is due 09/16/2016. [MJL] [Entered: 07/18/2016 12:07 PM] (78) |
